The relocation follows the sale of the downtown building as nearby adaptive reuse projects bring millions in investment to ...
Gilead Sciences Inc. is buying a private German biotech with U.S. operations in Cambridge — for over $3 billion, plus another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results